BioMarin Pharmaceutical (NASDAQ:BMRN) Price Target Raised to $60.00

Дата публикации: 10-08-2026 06:00:47

BioMarin Pharmaceutical (NASDAQ:BMRN – Free Report) had its price objective increased by HC Wainwright from $50.00 to $60.00 in a research note released on Friday,Benzinga reports. They currently have a neutral rating on the biotechnology company’s stock. A number of other equities analysts also recently issued reports on BMRN. Citigroup lifted their price target on […]

Схожие новости

#	Наименование новости	Тональность	Информативность	Дата публикации
1	AMN Healthcare Services (NYSE:AMN) Price Target Raised to $35.00	0	10.79	10-08-2026
2	Royalty Pharma (NASDAQ:RPRX) Price Target Raised to $62.00	0	13.82	10-08-2026
3	Celldex Therapeutics (NASDAQ:CLDX) Price Target Raised to $53.00	0	11.84	10-08-2026
4	Fidelity National Financial (NYSE:FNF) Price Target Raised to $54.00	0	11.13	10-08-2026
5	Marathon Digital’s (MARA) “Buy” Rating Reiterated at Rosenblatt Securities	0	7.71	10-08-2026
6	Genmab A/S (NASDAQ:GMAB) Price Target Raised to $42.00	0	9.76	10-08-2026
7	Miami International (NYSE:MIAX) Price Target Raised to $48.00	0	13.83	10-08-2026
8	BP (NYSE:BP) Price Target Raised to $43.00	0	12.22	10-08-2026
9	PubMatic (NASDAQ:PUBM) Price Target Raised to $23.00	0	11.49	10-08-2026
10	Cantor Fitzgerald Cuts Marathon Digital (NASDAQ:MARA) Price Target to $12.00	0	11.83	10-08-2026

Классификация: Пресс-релизы. Схожих патентов: 0. Схожих новостей: 10. Тональность: 0. Информативность: 12.21. Источник: www.americanbankingnews.com.